Fibromyalgia Syndrome: Science or Somatic?
Including proceedings from a national symposium series
Activity Date: December 2009 — Activity Info: Volume 9, (4)
 

Goal
To provide primary care physicians and advanced practice nurses with up-to-date information on the treatment and management of patients with fibromyalgia syndrome.

Target Audience
This activity is designed for primary care physicians and advanced practice nurses. No prerequisites required.

Learning Objectives
Upon the conclusion of this activity, the participant should be able to:

  • Explain dysregulation of neurotransmitters in patients with fibromyalgia syndrome (FMS) and how it relates to pain response.
  • Evaluate current diagnostic criteria and neuroimaging diagnostics supporting the evidence of central sensitization, as well as genetic polymorphisms.
  • Identify clinician barriers encountered when treating patients with FMS and develop strategies to increase quality of patient care.
  • Compare and contrast the efficacy and safety of targeted neurotransmitter therapies and nonmedicinal therapies used to treat FMS.
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The estimated time to complete this educational activity: 2 hours.

After reading this monograph, participants may receive credit by completing the CME test, evaluation, and receiving a score of 70% or higher.

Release date: December 15, 2009. Expiration date: December 15, 2011.

Disclaimer Statement
The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

This activity is supported by an educational grant from Lilly USA, LLC and Pfizer Inc.

Johns Hopkins Advanced Studies in Medicine (ISSN-1530-3004) is published by Galen Publishing, LLC, d/b/a Advanced Studies in Medicine, an HMG Company, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2009 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. Advanced Studies in Medicine is a registered trademark of The Healthcare Media Group, LLC.

 
 
     
 
Home | Contact Us | View Account | Need Help?
Johns Hopkins Advanced Studies in Medicine (ISSN-1558-0334) is published by Galen Publishing, LLC, d/b/a ASiM, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2010 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of The Healthcare Media Group, LLC.